Viewing Study NCT00570492


Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2026-02-25 @ 5:53 PM
Study NCT ID: NCT00570492
Status: COMPLETED
Last Update Posted: 2017-09-15
First Post: 2007-12-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-11-26
Start Date Type: None
Primary Completion Date: 2011-03-01
Primary Completion Date Type: ACTUAL
Completion Date: 2011-03-17
Completion Date Type: ACTUAL
First Submit Date: 2007-12-06
First Submit QC Date: None
Study First Post Date: 2007-12-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-11-03
Results First Submit QC Date: None
Results First Post Date: 2012-02-07
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-08-17
Last Update Post Date: 2017-09-15
Last Update Post Date Type: ACTUAL